BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3005834)

  • 21. [Effects of nicardipine and chlorpromazine on proliferation and intracellular calmodulin in cultured aortic smooth muscle cells].
    Lu ZQ; Wang DS
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):450-4. PubMed ID: 2130602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on calmodulin of bepridil, an antianginal agent.
    Itoh H; Ishikawa T; Hidaka H
    J Pharmacol Exp Ther; 1984 Sep; 230(3):737-41. PubMed ID: 6088765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calcium-calmodulin and vasomotor activity].
    Lugnier C
    Arch Mal Coeur Vaiss; 1991 Jan; 84 Spec No 1():25-34. PubMed ID: 2053831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relaxation of skinned coronary arteries depends on the relative concentrations of Ca2+, calmodulin and active cAMP-dependent protein kinase.
    Pfitzer G; Rüegg JC; Zimmer M; Hofmann F
    Pflugers Arch; 1985 Sep; 405(1):70-6. PubMed ID: 4059032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chlorpromazine (CPZ) on cholecystokinin-induced gallbladder contraction: the role of calcium.
    Pomeranz IS; Davison JS; Shaffer EA
    Isr J Med Sci; 1988 Jun; 24(6):275-81. PubMed ID: 2900226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of calcium entry blockers and calmodulin inhibitors on 5-hydroxytryptamine-, potassium- and calcium-induced contractions in human umbilical artery in-vitro.
    Medeiros YS; Calixto JB
    J Pharm Pharmacol; 1991 Jun; 43(6):411-6. PubMed ID: 1681054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin antagonistic action of the cerebral circulation improver 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-4- ([4-(2-methoxyphenyl)-1-piperazinyl]methyl)isoquinoline.
    Nakajima T; Okada T; Kuruma I; Yoshizaki H; Satoh T; Kuwahara T; Nakamura K
    Arzneimittelforschung; 1987 Jun; 37(6):674-9. PubMed ID: 2822056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
    Stout MA; Silver PJ
    J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta.
    Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):262-8. PubMed ID: 2455529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of the vasodilating action of etozoline and its metabolites in guinea-pig aorta.
    Dorigo P; Belluco P; Corradi L; Gaion RM; Maragno I
    Arch Int Pharmacodyn Ther; 1990; 307():130-41. PubMed ID: 2095710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
    Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
    Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contraction-relaxation and Ca2+ mobilization in smooth muscle].
    Itoh T; Suzuki S
    Tanpakushitsu Kakusan Koso; 1991 May; 36(6):885-95. PubMed ID: 1650949
    [No Abstract]   [Full Text] [Related]  

  • 33. The Ca2+ -activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinase.
    Ito M; Tanaka T; Nunoki K; Hidaka H; Suzuki K
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1321-8. PubMed ID: 3038096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
    Tanaka M; Muramatsu M; Aihara H; Otomo S
    Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of cyclic peptides and depsipeptides with calmodulin.
    Mereish KA; Solow R; Bunner DL; Fajer AB
    Pept Res; 1990; 3(5):233-7. PubMed ID: 1724618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologically active fluorescent derivatives of spinach calmodulin that report calmodulin target protein binding.
    Mills JS; Walsh MP; Nemcek K; Johnson JD
    Biochemistry; 1988 Feb; 27(3):991-6. PubMed ID: 3365375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
    Tanaka T; Ito M; Ohmura T; Hidaka H
    Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of calmodulin antagonists with calcium antagonists binding sites.
    Schaeffer P; Lugnier C; Stoclet JC
    Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of isoproterenol on active force and Ca2+ X calmodulin-sensitive phosphodiesterase activity in porcine coronary artery.
    Miller JR; Wells JN
    Biochem Pharmacol; 1987 Jun; 36(11):1819-24. PubMed ID: 3034289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.